JPH09187248A - Antiallergic food - Google Patents

Antiallergic food

Info

Publication number
JPH09187248A
JPH09187248A JP8212016A JP21201696A JPH09187248A JP H09187248 A JPH09187248 A JP H09187248A JP 8212016 A JP8212016 A JP 8212016A JP 21201696 A JP21201696 A JP 21201696A JP H09187248 A JPH09187248 A JP H09187248A
Authority
JP
Japan
Prior art keywords
oil
thyme extract
group
weight
thyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8212016A
Other languages
Japanese (ja)
Inventor
Atsuro Nishina
淳良 仁科
Hidehiko Hibino
英彦 日比野
Hiroyuki Nakano
裕之 中野
Tatsuya Sugawara
達也 菅原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
Nippon Oil and Fats Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Oil and Fats Co Ltd filed Critical Nippon Oil and Fats Co Ltd
Priority to JP8212016A priority Critical patent/JPH09187248A/en
Publication of JPH09187248A publication Critical patent/JPH09187248A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Seasonings (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an antiallergic food composed of a natural product, having safety, easily absorbed, effective in prophylaxis and treatment of allergosis such as atopic dermatitis and free from side effect by compounding a thyme extract and an oil and fat. SOLUTION: Seeds of thyme are crushed in a ball mile, the crushed material is charged into a Soxhlet extractor together with ether, and the solvent is heated to reflux for 20hr. The solvent is removed from the obtained extraction liquid under reduced pressure to dry up the extract. The obtained thyme extract is mixed and homogenized under heating on a hot water bath at 60 deg.C with an oil and fat such as perilla oil, docosahexaenoic acid(DHA) oil, borage oil or evening primrose oil to obtain the objective antiallergic food. The obtained food is composed of a natural product, accordingly safe and easily absorbed, effective in prophylaxis and treatment of allergosis such as atopic dermatitis and free from side effect.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、抗アレルギー食品
に関する。さらに詳しくは、本発明は、タイム抽出物を
有効成分として含有し、アレルギー症状の予防及び治療
に効果のある抗アレルギー食品に関する。
TECHNICAL FIELD The present invention relates to an antiallergic food. More specifically, the present invention relates to an anti-allergic food containing thyme extract as an active ingredient and effective in preventing and treating allergic symptoms.

【0002】[0002]

【従来の技術】近年、アレルギー症状の患者が増加する
傾向にあるが、その直接の原因が、カビ、ダニ、花粉な
どに含まれるアレルゲンの増加のみに起因するのか、あ
るいは生体反応の上昇によるのかは解明されてはいな
い。アレルギー症状は、アレルゲンに対する体内で起こ
る抗原抗体反応により、免疫グロブリンE(IgE)が
産生され、結果的に肥満細胞の細胞膜が刺激され、ヒス
タミン、ロイコトリエンを放出することによって発生す
る。放出されたこれらの物質は、血管透過性を促進させ
る作用や、平滑筋を収縮させる作用などを有するため、
白血球や蛋白質が血管から漏出して炎症を誘発したり、
気管支を収縮させ喘息を起こしたりする。抗アレルギー
成分に関して、ボルネオールの肥満細胞膜安定化能(特
開平6−211713号公報)、放線菌培養液の炎症抑
制作用(特開平5−25053号公報)を利用した技術
が知られている。一方、奥山らによりα−リノレン酸を
油脂の形で食品として摂取することによって、アレルギ
ー反応の原因となるロイコトリエンの産生を抑制する効
果のあることが報告されている(Prostaglan
din、第36巻、第3号、1988年)。また、ドコ
サヘキサエン酸(DHA)や、α−リノレン酸を含む油
脂の抗アレルギー性を利用した技術(特開平2−290
812号公報)が知られている。しかし、これらの天然
の抗アレルギー剤は、副作用が少ないものの、いずれも
効果が十分とはいえない。アレルギー症状を軽減するた
めに、従来より、クロルフェニラミン、ジフェンヒドラ
ミンなどの抗ヒスタミン剤、クロモリン、トラニラスト
などの肥満細胞安定化剤、副腎皮質ホルモンなどを、経
口投与により、あるいは軟膏として用いてきた。しかし
ながら、抗ヒスタミン剤は眠気や口渇などの副作用があ
り、肥満細胞安定化剤にはすでに起こってしまった症状
を軽減する効果は期待できない。副腎皮質ホルモンは、
胃腸障害、肝臓障害、糖尿病、高血圧などの副作用をと
もなう。しかも、これらの薬剤はいずれも一時的な治療
に用いられ、使用を中断すると、再び症状が現れるなど
の問題があった。タイムは、スペイン原産のシソ科の植
物の葉や芽を乾燥したもので、防腐性の強い香辛料とし
て知られ、肉類の料理に広く用いられている。タイムの
薬理作用を利用する先行技術としては、衣類害虫用防虫
剤(特開平5−97618号公報)、美白化粧料(特開
平6−199647号公報)、皮膚外用剤(特開平7−
61915号公報)などが知られているが、タイムの抗
アレルギー性については知られていなかった。
2. Description of the Related Art In recent years, the number of patients with allergic symptoms tends to increase. Is it the direct cause of the increase in allergens contained in fungi, mites, pollen, etc., or is it due to an increase in biological reaction? Has not been elucidated. An allergic symptom occurs when an antigen-antibody reaction that occurs in the body against an allergen produces immunoglobulin E (IgE), and as a result, the cell membrane of mast cells is stimulated and histamine and leukotriene are released. These released substances have the action of promoting vascular permeability, the action of contracting smooth muscle, etc.,
Leukocytes and proteins leak from blood vessels and induce inflammation,
Bronchoconstriction causes asthma. Regarding the antiallergic component, a technique utilizing borneol's ability to stabilize mast cell membrane (Japanese Patent Laid-Open No. 6-2111713) and the anti-inflammatory action of actinomycete culture (Japanese Patent Laid-Open No. 5-25053) is known. On the other hand, it has been reported by Okuyama et al. That by ingesting α-linolenic acid in the form of oil and fat as a food, it has an effect of suppressing the production of leukotriene which causes an allergic reaction (Prostaglan).
din, Vol. 36, No. 3, 1988). Further, a technique utilizing the antiallergic properties of oils and fats containing docosahexaenoic acid (DHA) and α-linolenic acid (Japanese Patent Laid-Open No. 2-290).
No. 812) is known. However, although these natural antiallergic agents have few side effects, none of them are sufficiently effective. In order to reduce allergic symptoms, conventionally, antihistamines such as chlorpheniramine and diphenhydramine, mast cell stabilizers such as cromolyn and tranilast, and corticosteroids have been used orally or as an ointment. However, antihistamines have side effects such as drowsiness and dry mouth, and mast cell stabilizers cannot be expected to have the effect of reducing already occurring symptoms. Corticosteroids
It is accompanied by side effects such as gastrointestinal disorders, liver disorders, diabetes and high blood pressure. Moreover, all of these drugs are used for temporary treatment, and there is a problem that symptoms are reappeared when the drug is discontinued. Thyme is a dried leaf and bud of a Lamiaceae plant native to Spain, and is known as a highly antiseptic spice, and is widely used in meat dishes. As prior art utilizing the pharmacological action of thyme, insect repellents for clothes pests (JP-A-5-97618), whitening cosmetics (JP-A-6-199647), and skin external preparations (JP-A-7-76).
No. 61915 gazette) is known, but thyme's anti-allergic property has not been known.

【0003】[0003]

【発明が解決しようとする課題】本発明は、上記の薬剤
による治療の問題点を解決するために、天然物からなる
安全で摂取しやすく、しかも効果の大きい抗アレルギー
食品を提供することを目的としてなされたものである。
DISCLOSURE OF THE INVENTION In order to solve the above-mentioned problems of treatment with drugs, the present invention aims to provide an antiallergic food consisting of natural products, which is safe, easy to ingest, and highly effective. It was made as.

【0004】[0004]

【課題を解決するための手段】本発明者らは、上記の課
題を解決すべく鋭意研究を重ねた結果、タイム抽出物が
抗アレルギー食品として有効であり、しかも、タイム抽
出物と油脂を併用することにより、全く予期しない相乗
効果が発現することを見いだし、この知見に基づいて本
発明を完成するに至った。すなわち、本発明は、(1)
タイム抽出物を含有することを特徴とする抗アレルギー
食品、(2)タイム抽出物及び油脂を含有することを特
徴とする抗アレルギー食品、(3)油脂がエゴマ油であ
る第(2)項記載の抗アレルギー食品、(4)油脂がDH
A油である第(2)項記載の抗アレルギー食品、(5)油
脂がボラージ油である第(2)項記載の抗アレルギー食
品、及び、(6)油脂が月見草油である第(2)項記載の
抗アレルギー食品、を提供するものである。
As a result of intensive studies to solve the above problems, the present inventors have found that thyme extract is effective as an antiallergic food, and that thyme extract is used in combination with fats and oils. By doing so, it was found that a completely unexpected synergistic effect was developed, and the present invention was completed based on this finding. That is, the present invention provides (1)
An anti-allergic food characterized by containing a thyme extract, (2) an anti-allergic food characterized by containing a thyme extract and fats and oils, (3) the fat and oil is perilla oil (2). Anti-allergic food, (4) fat and oil is DH
The anti-allergic food according to item (2), which is oil A, (5) the anti-allergic food according to item (2), wherein the fat and oil is borage oil, and (6) the item (2), which is evening primrose oil. An anti-allergic food according to the above item is provided.

【0005】[0005]

【発明の実施の形態】本発明の抗アレルギー食品は、タ
イム抽出物を有効成分として含有する。タイム(thy
me)は、シソ科の植物 Thymus serpyll
um L.、Thymus vulgaris L.、T
hymus pruecox Opiz.、Thymu
s pannonocs L.、Thymus doe
rflert Ronn.、Thymus caesp
ittius Brot.などであって、古くより香辛
料の原料として栽培されている小低木である。本発明に
用いるタイム抽出物を得る方法には特に制限はなく、任
意の公知の抽出方法によることができる。例えば、原料
のタイムの乾燥した実、若芽、葉、茎、根などをボール
ミルなどを用いて粉砕し、次いで、水、エタノール、n
−ヘキサン、エーテル、アセトンなどの溶媒で抽出し、
抽出液の加熱などにより溶媒を除去することにより、タ
イム抽出物を得ることができる。また、必要に応じて、
クロマトグラフィーなどにより、さらに精製することが
できる。本発明の抗アレルギー食品は、タイム抽出物を
含有せしめることができるものであれば形態には特に制
限はなく、例えば、タイム抽出物をそのまま封入したカ
プセル、タイム抽出物の油脂懸濁液を封入したカプセ
ル、タイム抽出物と吸油性でんぷんなどを混合して得ら
れる粉末などのほか、キャンディー、ドロップ、錠菓、
チューインガム、ゼラチンカプセル錠、飲料などとする
ことができる。タイム抽出物を含有する本発明の抗アレ
ルギー食品を、カプセル錠とすることにより、容易に摂
取することができる。また、タイム抽出物を、あらかじ
めグリセリン脂肪酸エステル、プロピレングリコール脂
肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪
酸エステル、レシチン、グリセリンなどと混合し、均一
な乳化状態としておき、これらの混合物を食品に使われ
る一般的な原料に配合、分散して、所望の形態に加工す
ることができる。本発明の抗アレルギー食品において、
タイム抽出物の含有量は0.1〜100重量%であるこ
とが好ましい。タイム抽出物の含有量が0.1重量%未
満であると、抗アレルギー性が十分に発現しないおそれ
がある。
BEST MODE FOR CARRYING OUT THE INVENTION The antiallergic food of the present invention contains thyme extract as an active ingredient. Time
me) is a plant of the Labiatae family, Thymus serpyll.
um L. , Thymus vulgaris L .; , T
hymus purecox Opiz. , Thymu
s pannonocs L.S. , Thymus doe
rflert Ronn. , Thymus caesp
ittius Brot. It is a small shrub that has been cultivated as a raw material for spices since ancient times. The method for obtaining the thyme extract used in the present invention is not particularly limited, and any known extraction method can be used. For example, the dried thyme, sprouts, leaves, stems, roots, etc. of the raw material thyme are crushed using a ball mill or the like, and then water, ethanol, n
-Extract with a solvent such as hexane, ether, acetone,
The thyme extract can be obtained by removing the solvent by heating the extract or the like. Also, if necessary,
It can be further purified by chromatography or the like. The anti-allergic food of the present invention is not particularly limited in form as long as it can contain thyme extract, for example, a capsule containing thyme extract as it is, a fat suspension containing thyme extract. Capsules, powder obtained by mixing thyme extract and oil-absorbing starch, candy, drops, confectionery,
It can be chewing gum, gelatin capsule tablets, beverages and the like. The antiallergic food of the present invention containing a thyme extract can be easily ingested by forming a capsule tablet. In addition, thyme extract is mixed with glycerin fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, lecithin, glycerin, etc. in advance to obtain a uniform emulsified state, and these mixtures are generally used in foods. It can be mixed and dispersed in a specific raw material and processed into a desired form. In the antiallergic food of the present invention,
The content of the thyme extract is preferably 0.1 to 100% by weight. If the content of the thyme extract is less than 0.1% by weight, the antiallergic property may not be sufficiently exhibited.

【0006】本発明の抗アレルギー食品は、タイム抽出
物及び油脂を併せて配合することにより、抗アレルギー
性が一層強く発揮される。本発明の抗アレルギー食品に
油脂を含有せしめる場合は、油脂の含有量は1〜99重
量%であることが好ましく、10〜50重量%であるこ
とがより好ましい。油脂の含有量が1重量%未満である
と、抗アレルギー性の増強効果が顕著に発現しないおそ
れがある。また、油脂の含有量が99重量%を超える
と、相対的にタイム抽出物の含有量が少なくなり、結果
的に抗アレルギー性が低下するおそれがある。本発明に
おいて使用する油脂には特に制限はなく、例えば、アマ
ニ油、エゴマ油、カヤ油、サフラワー油、大豆油などの
乾性油、ゴマ油、コーン油、ナタネ油、綿実油、レモン
油などの半乾性油、ウイキョウ油、オリーブ油、カポッ
ク油、ツバキ油、落花生油などの不乾性油、カカオ脂、
シア脂、パーム油、ヤシ油などの植物脂、牛酪脂、豚
脂、馬脂などの陸産動物油、イワシ油、カツオ油、サン
マ油、ニシン油、マグロ油などの魚油、サメ類、エイ類
などの肝油、鯨油、イルカ油などの海獣油などを挙げる
ことができる。これらの油脂の中で、α−リノレン酸を
含むエゴマ油、シソ油など、γ−リノレン酸を含むボラ
ージ油、月見草油など、ドコサヘキサエン酸(DH
A)、エイコサペンタエン酸(EPA)を含む精製魚油
などが好ましく、特にα−リノレン酸を含むエゴマ油、
ドコサヘキサエン酸を含むDHA油、γ−リノレン酸を
含むボラージ油及びγ−リノレン酸を含む月見草油を好
適に使用することができる。これらの油脂はいずれも市
販されており、容易に入手して使用することができる。
In the antiallergic food of the present invention, the antiallergic property is exerted more strongly by combining thyme extract and fats and oils together. When the antiallergic food of the present invention contains oil and fat, the content of oil and fat is preferably 1 to 99% by weight, more preferably 10 to 50% by weight. When the content of the fats and oils is less than 1% by weight, the antiallergic enhancing effect may not be remarkably exhibited. On the other hand, when the content of fats and oils exceeds 99% by weight, the content of thyme extract becomes relatively small, and as a result, the antiallergic property may be lowered. There is no particular limitation on the fats and oils used in the present invention, for example, linseed oil, perilla oil, kaya oil, safflower oil, soybean oil and other drying oils, sesame oil, corn oil, rapeseed oil, cottonseed oil, lemon oil and other semi-oils. Non-drying oils such as drying oil, fennel oil, olive oil, kapok oil, camellia oil, peanut oil, cocoa butter,
Shea butter, palm oil, vegetable oil such as coconut oil, land animal oil such as beef butter, pork and horse fat, sardine oil, bonito oil, fish oil such as saury oil, herring oil and tuna oil, sharks, rays Examples thereof include liver oil, whale oil, sea animal oil such as dolphin oil, and the like. Among these fats and oils, perilla oil containing α-linolenic acid, perilla oil, borage oil containing γ-linolenic acid, evening primrose oil, docosahexaenoic acid (DH
A), purified fish oil containing eicosapentaenoic acid (EPA) and the like are preferable, and especially sesame oil containing α-linolenic acid,
DHA oil containing docosahexaenoic acid, borage oil containing γ-linolenic acid, and evening primrose oil containing γ-linolenic acid can be preferably used. All of these fats and oils are commercially available and can be easily obtained and used.

【0007】本発明の抗アレルギー食品において、タイ
ム抽出物とエゴマ油を併用することにより、タイム抽出
物とエゴマ油の抗アレルギー性に相乗効果が現れ、タイ
ム抽出物を単独で使用する場合と比較して、同等あるい
はそれ以上の抗アレルギー効果が発現する。タイム抽出
物とエゴマ油を併用する場合、その割合には特に制限は
ないが、タイム抽出物10〜40重量%とエゴマ油90
〜60重量%であることが好ましく、タイム抽出物15
〜30重量%とエゴマ油85〜70重量%であることが
より好ましい。エゴマ油(perrila oil)
は、シソ科の植物Pellia ocymoidesの
種子から得られるリノール酸及びα−リノレン酸を主成
分とする油である。エゴマ油の搾油方法には特に制限は
なく、例えば、種子を熱したのち搗き砕き、圧搾するこ
とにより得ることができる。本発明の抗アレルギー食品
において、DHA油にタイム抽出物を少量添加すること
により、抗アレルギー性の効果が強く発現し、タイム抽
出物のみを使用した場合と同等又はそれ以上の優れた抗
アレルギー効果が得られる。タイム抽出物をDHA油に
添加する場合、その割合には特に制限はないが、タイム
抽出物0.1〜20重量%とDHA油99.9〜80重量
%であることが好ましく、タイム抽出物0.5〜10重
量%とDHA油99.5〜90重量%であることがより
好ましい。DHA油は、ω−3脂肪酸であるドコサヘキ
サエン酸(DHA)を含む油脂であって、カツオ油、マ
グロ油、精製魚油などから得ることができる。
In the antiallergic food of the present invention, the combined use of thyme extract and sesame oil has a synergistic effect on the antiallergic properties of thyme extract and sesame oil, which is compared with the case where thyme extract is used alone. Then, an antiallergic effect equivalent to or higher than that is exhibited. When thyme extract and perilla oil are used in combination, the ratio is not particularly limited, but 10 to 40 wt% of thyme extract and perilla oil 90 can be used.
˜60% by weight, thyme extract 15
More preferably, the content is ˜30 wt% and the sesame oil is 85 to 70 wt%. Perilla oil
Is an oil containing linoleic acid and α-linolenic acid as main components, which is obtained from the seeds of the plant Lamiaceae Pellia ocymoides. The method of squeezing the sesame oil is not particularly limited, and it can be obtained, for example, by heating seeds, then crushing them and squeezing them. In the antiallergic food of the present invention, by adding a small amount of thyme extract to DHA oil, an antiallergic effect is strongly expressed, and an excellent antiallergic effect equivalent to or higher than the case where only thyme extract is used. Is obtained. When the thyme extract is added to DHA oil, the proportion thereof is not particularly limited, but it is preferable that the thyme extract is 0.1 to 20% by weight and the DHA oil is 99.9 to 80% by weight. More preferably, it is 0.5 to 10% by weight and DHA oil is 99.5 to 90% by weight. DHA oil is an oil and fat containing docosahexaenoic acid (DHA), which is an ω-3 fatty acid, and can be obtained from bonito oil, tuna oil, refined fish oil and the like.

【0008】本発明の抗アレルギー食品において、ボラ
ージ油にタイム抽出物を少量添加することにより、抗ア
レルギー性の効果が強く発現し、タイム抽出物のみを使
用した場合と同等又はそれ以上の優れた抗アレルギー効
果が得られる。タイム抽出物をボラージ油に添加する場
合、その割合には特に制限はないが、タイム抽出物0.
1〜20重量%とボラージ油99.9〜80重量%であ
ることが好ましく、タイム抽出物0.5〜10重量%と
ボラージ油99.5〜90重量%であることがより好ま
しい。ボラージ油は、ムラサキ科の植物 Borago
officinalis L.の種子から得られるγ
−リノレン酸を多量に含む油である。搾油後、酸処理、
分子蒸留、脱臭の工程を経て精製油とすることができ
る。本発明の抗アレルギー食品において、タイム抽出物
と月見草油を併用することにより、タイム抽出物と月見
草油の抗アレルギー性に相乗効果が現れ、タイム抽出物
を単独で使用する場合と比較して、同等あるいはそれ以
上の抗アレルギー効果が発現する。タイム抽出物と月見
草油を併用する場合、その割合には特に制限はないが、
タイム抽出物10〜40重量%と月見草油90〜60重
量%であることが好ましく、タイム抽出物15〜30重
量%と月見草油85〜70重量%であることがより好ま
しい。月見草油は、アカバナ科の植物 Oenothe
ratetrapteraの種子から得られるγ−リノ
レン酸を含有する油である。本発明の抗アレルギー食品
は、そのまま経口摂取することも可能であるが、カプセ
ル、錠剤、乳剤などにして摂取することができる。本発
明の抗アレルギー食品の摂取量は、タイム抽出物の量と
して成人1日当たり300〜10,000mgであること
が好ましく、1,000〜5,000mgであることがより
好ましく、2,000〜3,000mgであることがさらに
好ましい。通常は、成人1日当たりの摂取量2,000
〜3,000mgで十分な効果が認められる。本発明の抗
アレルギー食品は、天然物より構成されているために安
全であり、かつ製造がきわめて容易である。また、本発
明の抗アレルギー食品は、通常の食生活の中で自然に摂
取することができ、特にタイム抽出物と油脂を併用した
ときは、相乗的にアレルギー症状に対して顕著な抑制効
果を示す。
In the antiallergic food of the present invention, by adding a small amount of thyme extract to borage oil, the antiallergic effect is strongly expressed, and it is as excellent as or better than the case where only thyme extract is used. Anti-allergic effect is obtained. When thyme extract is added to borage oil, the ratio is not particularly limited, but thyme extract 0.1%.
1 to 20 wt% and borage oil 99.9 to 80 wt% are preferable, and thyme extract 0.5 to 10 wt% and borage oil 99.5 to 90 wt% are more preferable. Borage oil is a plant of the family Musaceae Borago
officinalis L. Γ obtained from the seeds of
An oil that is rich in linolenic acid. After oiling, acid treatment,
A refined oil can be obtained through the steps of molecular distillation and deodorization. In the anti-allergic food of the present invention, by using thyme extract and evening primrose oil in combination, a synergistic effect appears in the anti-allergic properties of thyme extract and evening primrose oil, compared to the case of using thyme extract alone. An equivalent or higher anti-allergic effect is developed. When using thyme extract and evening primrose oil in combination, the ratio is not particularly limited,
The thyme extract is preferably 10 to 40% by weight and the evening primrose oil is 90 to 60% by weight, and more preferably the thyme extract is 15 to 30% by weight and the evening primrose oil is 85 to 70% by weight. Evening primrose oil is a plant of the family Acabbaceae Oenothe
It is an oil containing γ-linolenic acid obtained from the seeds of ratetraptera. The anti-allergic food of the present invention can be orally ingested as it is, but can be ingested as a capsule, tablet, emulsion or the like. The intake of the antiallergic food of the present invention is preferably 300 to 10,000 mg, more preferably 1,000 to 5,000 mg, and more preferably 2,000 to 3 as an amount of thyme extract per day for an adult. More preferably, it is 1,000 mg. Usually, adults take 2,000 per day
A sufficient effect is recognized at ~ 3,000 mg. The antiallergic food of the present invention is safe because it is composed of natural products, and is extremely easy to manufacture. Further, the anti-allergic food of the present invention can be naturally taken in a normal diet, especially when the thyme extract and fats and oils are used in combination, synergistically exhibit a remarkable inhibitory effect on allergic symptoms. Show.

【0009】[0009]

【実施例】以下に、実施例を挙げて本発明をさらに詳細
に説明するが、本発明はこれらの実施例によりなんら限
定されるものではない。 製造例1(タイム抽出物の製造) タイムの実1kgをボールミルで粉砕し、エーテル5,0
00mlとともにソックスレー抽出器に仕込み、20時間
加熱還流した。得られた抽出液を減圧乾固し、淡褐色の
タイム抽出物45.3gを得た。 製造例2(タイム抽出物の製造) 乾燥したタイムの葉1kgをボールミルで粉砕し、メタノ
ール5,000mlを加えて10日間放置した。得られた
抽出液を減圧乾固し、濃緑色のタイム抽出物38.3g
を得た。 製造例3(タイム抽出物の製造) 乾燥したタイムの葉1kgをボールミルで粉砕し、エタノ
ール5,000mlとともにソックスレー抽出器に仕込
み、20時間加熱還流した。得られた抽出液を減圧乾固
し、濃緑色のタイム抽出物43.2gを得た。 製造例4(タイム抽出物の製造) 乾燥したタイムの葉1kgをボールミルで粉砕し、3重量
%水酸化ナトリウム水溶液10リットルを加えて10日
間放置した。ヌッチェでろ過して、得られた抽出液のpH
を、1規定の塩酸を用いて7.0に調節したのち真空凍
結乾燥し、塩化ナトリウムを含む褐色のタイム抽出物5
11.9gを得た。 実施例1(カプセル) シームレスカプセル製造機[フロイント産業(株)製品]
を用いて、1粒当たり製造例1のタイム抽出物を240
mg含むカプセルを調製した。 実施例2(カプセル) エゴマ油[α−リノレン酸含有量55重量%:日本油脂
(株)製品]80重量部と製造例1のタイム抽出物20重
量部を湯浴上で60℃に加熱しながら混合して均質化
し、抗アレルギー食品を得た。さらにシームレスカプセ
ル製造機[フロイント産業(株)製品]を用いて、1粒当
たり上記の抗アレルギー食品を240mg含むカプセルを
調製した。 実施例3(粉末) 製造例2のタイム抽出物50重量部と吸油性でんぷん
[商品名パインフロー:松谷化学(株)製品]50重量部
をリボンミキサーで混合して粉末を調製し、抗アレルギ
ー食品を得た。 実施例4(粉末) DHA油[DHA含有量27重量%:日本油脂(株)製
品]98重量部と製造例2のタイム抽出物2重量部を湯
浴上で60℃に加熱しながら混合したのち、マイクロフ
ルイダイザー[マイクロフルイド社製品:均質化圧力5
00kg/cm2]を用いて均質化し、タイム抽出物のDH
A油懸濁液を得た。さらに、このタイム抽出物のDHA
懸濁液50重量部と吸油性でんぷん[商品名パインフロ
ー:松谷化学(株)製品]50重量部をリボンミキサーで
混合して粉末を調製し、抗アレルギー食品を得た。 実施例5(カプセル) ボラージ油[γ−リノレン酸含有量25重量%:日本油
脂(株)製品]99重量部と製造例3のタイム抽出物1重
量部を湯浴上で60℃に加熱しながら混合して均質化
し、タイム抽出物のボラージ油懸濁液を得た。さらにシ
ームレスカプセル製造機[フロイント産業(株)製品]を
用いて、このタイム抽出物のボラージ油懸濁液を1粒当
たり240mg含むカプセルを調製した。 実施例6(粉末) DHA油[DHA含有量27重量%:日本油脂(株)製
品]90重量部と製造例4のタイム抽出物10重量部を
湯浴上で60℃に加熱しながら混合したのち、マイクロ
フルイダイザー[マイクロフルイド社:均質化圧力50
0kg/cm2]を用いて均質化し、タイム抽出物のDHA
懸濁液を得た。さらにこのタイム抽出物のDHA懸濁液
50重量部と吸油性でんぷん[商品名パインフロー:松
谷化学(株)製品]50重量部とをリボンミキサーで混合
して粉末を調製した。 実施例7(カプセル) エゴマ油[α−リノレン酸含有量55重量%:日本油脂
(株)製品]80重量部、製造例3のタイム抽出物15重
量部及びカルナウバロウ5重量部を湯浴上で60℃に加
熱しながら混合したのち、マイクロフルイダイザー[マ
イクロフルイド社:均質化圧力500kg/cm2]を用い
て均質化し、タイム抽出物のエゴマ油懸濁液を得た。シ
ームレスカプセル製造機[フロイント産業(株)製品]を
用いて、このタイム抽出物のエゴマ油懸濁液を1粒当た
り240mg含むカプセルを調製した。 比較例1(エゴマ油含有カプセル) シームレスカプセル製造機[フロイント産業(株)製品]
を用いて、エゴマ油[α−リノレン酸含有量55重量
%:日本油脂(株)製品]を1粒当たり240mg含むカプ
セルを調製した。 比較例2(DHA油含有粉末) DHA油[DHA含有量27重量%:日本油脂(株)製
品]50重量部と吸油性でんぷん[商品名パインフロ
ー:松谷化学(株)製品]50重量部をリボンミキサーで
混合して粉末を調製し、食品を得た。 実施例8(アレルギー性鼻炎に対する臨床試験) アレルギー性鼻炎(花粉症)患者、計30名(男14
名、女16名、22〜43歳)を、10名ずつA群、B
群及びC群の3群に分けて、2カ月間にわたって臨床試
験を行った。A群の患者には、実施例1で調製したタイ
ム抽出物を含有するカプセルを投与し、B群の患者には
比較例1で調製したエゴマ油を含有するカプセルを投与
し、C群の患者には実施例2で調製したタイム抽出物2
0重量%及びエゴマ油80重量%の混合物を含有するカ
プセルを投与した。試験方法は、花粉症状が患者に現れ
たときから、被験者に毎日10錠ずつカプセルを経口投
与した。一方、食事など生活活動は特に制限しなかっ
た。診断は試験開始日より2週間後、1カ月後及び2カ
月後の計3回実施した。効果の判定は、被験者の自覚症
状をもとに、著効、有効、無効、悪化の4段階で評価し
た。また、著効及び有効とした患者数の合計を被験者数
で除して、改善率を求めた。A群の患者は、2週間後に
有効2名、無効8名で改善率20%、1カ月後に有効4
名、無効6名で改善率40%、2カ月後に著効4名、有
効4名、無効2名で改善率80%であった。B群の患者
は、2週間後に有効2名、無効8名で改善率20%、1
カ月後に有効3名、無効7名で改善率30%、2カ月後
に有効4名、無効6名で改善率40%であった。C群の
患者は、2週間後に有効4名、無効6名で改善率40
%、1カ月後に著効2名、有効6名、無効2名で改善率
80%、2カ月後に著効6名、有効4名で改善率100
%であった。臨床試験の結果をまとめて第1表に示す。
EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention. Production Example 1 (Production of thyme extract) 1 kg of thyme was crushed with a ball mill to give ether 5.0
It was charged into a Soxhlet extractor together with 00 ml and heated under reflux for 20 hours. The obtained extract was dried under reduced pressure to obtain 45.3 g of a light brown thyme extract. Production Example 2 (Production of thyme extract) 1 kg of dried thyme leaves was crushed with a ball mill, 5,000 ml of methanol was added, and the mixture was left for 10 days. The obtained extract was dried under reduced pressure to give 38.3 g of dark green thyme extract.
I got Production Example 3 (Production of thyme extract) 1 kg of dried thyme leaf was crushed with a ball mill, placed in a Soxhlet extractor with 5,000 ml of ethanol, and heated under reflux for 20 hours. The obtained extract was dried under reduced pressure to obtain 43.2 g of a dark green thyme extract. Production Example 4 (Production of thyme extract) 1 kg of dried thyme leaves was ground with a ball mill, 10 liters of a 3 wt% sodium hydroxide aqueous solution was added, and the mixture was allowed to stand for 10 days. The pH of the extract obtained by filtration through Nutsche
Was adjusted to 7.0 with 1N hydrochloric acid and then freeze-dried under vacuum to obtain a brown thyme extract containing sodium chloride 5
11.9 g was obtained. Example 1 (capsule) Seamless capsule manufacturing machine [Freund Industrial Co., Ltd. product]
240 g of the thyme extract of Production Example 1 per
Capsules containing mg were prepared. Example 2 (capsule) Perilla oil [α-linolenic acid content 55% by weight: NOF
[Products] 80 parts by weight and 20 parts by weight of the thyme extract of Production Example 1 were mixed while heating to 60 ° C. in a hot water bath to homogenize to obtain an antiallergic food. Furthermore, a capsule containing 240 mg of the above-mentioned antiallergic food per grain was prepared using a seamless capsule manufacturing machine [Freund Industrial Co., Ltd.]. Example 3 (powder) 50 parts by weight of the thyme extract of Production Example 2 and 50 parts by weight of oil-absorbing starch [trade name Pineflow: Matsutani Chemical Co., Ltd. product] were mixed with a ribbon mixer to prepare a powder, and antiallergic. Got food. Example 4 (powder) 98 parts by weight of DHA oil [DHA content: 27% by weight: NOF Corporation product] and 2 parts by weight of the thyme extract of Production Example 2 were mixed while heating to 60 ° C. in a hot water bath. Later, Microfluidizer [Microfluid's product: homogenizing pressure 5
00kg / cm 2 ] and homogenized using DH of thyme extract
An A oil suspension was obtained. Furthermore, DHA of this thyme extract
50 parts by weight of the suspension and 50 parts by weight of oil-absorbing starch [trade name Pineflow: product of Matsutani Chemical Co., Ltd.] were mixed with a ribbon mixer to prepare a powder to obtain an antiallergic food. Example 5 (Capsule) Borage oil [γ-linolenic acid content 25% by weight: NOF Corporation product] 99 parts by weight and 1 part by weight of the thyme extract of Production Example 3 were heated to 60 ° C. in a water bath. While mixing, homogenize to obtain a borage oil suspension of thyme extract. Furthermore, a capsule containing 240 mg of borage oil suspension of this thyme extract was prepared using a seamless capsule manufacturing machine [Freund Industrial Co., Ltd.]. Example 6 (powder) 90 parts by weight of DHA oil [DHA content 27% by weight: NOF Corporation product] and 10 parts by weight of the thyme extract of Production Example 4 were mixed while heating to 60 ° C. in a hot water bath. After that, Microfluidizer [Microfluid: Homogenization pressure 50
0 kg / cm 2 ] and homogenized with DHA of thyme extract
A suspension was obtained. Further, 50 parts by weight of a DHA suspension of this thyme extract and 50 parts by weight of oil-absorbing starch [trade name Pineflow: a product of Matsutani Chemical Co., Ltd.] were mixed with a ribbon mixer to prepare a powder. Example 7 (capsule) Perilla oil [α-linolenic acid content 55% by weight: NOF
Products Co., Ltd.] 80 parts by weight, 15 parts by weight of the thyme extract of Production Example 3 and 5 parts by weight of carnauba wax were mixed while heating to 60 ° C. in a hot water bath, and then mixed with Microfluidizer [Microfluid Company: Homogenization pressure]. 500 kg / cm 2 ] to obtain a suspension of thyme extract in perilla oil. Capsules containing 240 mg of the perilla oil suspension of this thyme extract were prepared using a seamless capsule manufacturing machine [Freund Industrial Co., Ltd.]. Comparative Example 1 (perilla oil-containing capsule) Seamless capsule manufacturing machine [Freund Industrial Co., Ltd. product]
Was used to prepare a capsule containing 240 mg of perilla oil [α-linolenic acid content 55% by weight: manufactured by NOF CORPORATION]. Comparative Example 2 (DHA oil-containing powder) 50 parts by weight of DHA oil [DHA content: 27% by weight: NOF Corporation product] and oil-absorbing starch [trade name: Pineflow: Matsutani Chemical Co., Ltd. product] Powder was prepared by mixing with a ribbon mixer to obtain a food product. Example 8 (Clinical test for allergic rhinitis) 30 patients (male 14) with allergic rhinitis (hay fever) patients
First name, 16 women, 22 to 43 years old), 10 people each in A group, B
The clinical trial was conducted for 2 months by dividing into 3 groups of a group and a group C. Patients in group A were administered capsules containing the thyme extract prepared in Example 1, patients in group B were administered capsules containing perilla oil prepared in comparative example 1, patients in group C were administered. Contains thyme extract 2 prepared in Example 2.
Capsules containing a mixture of 0% by weight and 80% by weight of sesame oil were administered. As a test method, 10 capsules were orally administered to the test subject every day after pollen symptoms appeared in the patient. On the other hand, daily activities such as eating were not limited. Diagnosis was performed 3 times in total, 2 weeks, 1 month and 2 months after the test start date. The effect was evaluated on the basis of the subjective symptoms of the test subject, and evaluated in four grades of excellent, effective, ineffective, and worse. In addition, the improvement rate was obtained by dividing the total number of patients who were markedly effective and effective by the number of subjects. Patients in group A were effective 2 after 2 weeks and ineffective 8 and had an improvement rate of 20% and effective 4 months later.
The improvement rate was 40% for 6 subjects and 6 invalid subjects, and the improvement rate was 80% for 4 subjects, 4 effective subjects and 2 invalid subjects after 2 months. After 2 weeks, patients in group B were effective 2 and ineffective 8 and the improvement rate was 20%, 1
After 3 months, the improvement rate was 30% in 3 effective patients and 7 ineffective patients, and the improvement rate was 40% in 4 effective patients and 6 ineffective patients after 2 months. After 2 weeks, the patients in group C were 4 effective and 6 ineffective, and the improvement rate was 40.
%, Improvement rate of 80% for 2 respondents, 6 effective and 2 invalid after 1 month, 100 improvement for 6 effective and 4 effective after 2 months
%Met. The results of the clinical trials are summarized in Table 1.

【0010】[0010]

【表1】 [Table 1]

【0011】第1表の結果から、タイム抽出物を投与し
たA群の患者の改善率は、エゴマ油を投与したB群の患
者の改善率より高く、タイム抽出物がエゴマ油よりもア
レルギー性鼻炎において抗アレルギー性が強いことが分
かった。さらに、全く予期しないことに、タイム抽出物
のみを投与したA群の患者の改善率よりも、タイム抽出
物とエゴマ油の混合物を投与したC群の患者の方が改善
率が高く、C群の患者には効果が早期に現れ、しかもC
群の患者には著効を認めるものが多いことから、タイム
抽出物とエゴマ油を併用することにより、顕著な相乗効
果が発現することが分かった。 実施例9(アトピー性皮膚炎に対する臨床試験) アトピー性皮膚炎患者30名(男18名、女12名、5
〜32歳)を、10名ずつA群、B群及びC群の3群に
分けて、3カ月間にわたって臨床試験を行った。A群の
患者には、実施例3で調製したタイム抽出物を含有する
抗アレルギー食品を投与し、B群の患者には比較例2で
調製したDHA油を含有する食品を投与し、C群の患者
には実施例4で調製したタイム抽出物2重量%及びDH
A油98重量%の混合物を含有する抗アレルギー食品を
投与した。試験方法は、各患者に毎日5gずつタイム抽
出物、DHA油又はタイム抽出物とDHA油を含有する
食品を経口投与した。一方、試験中の入浴、食事は特に
制限はしなかった。診断は試験開始日より1カ月後、2
カ月後及び3カ月後の計3回実施した。効果の判定は、
被験者及び試験者の意見をもとに、著効、有効、無効、
悪化の4段階で評価した。また、著効及び有効とした患
者数の合計を被験者数で除して、改善率を求めた。A群
の患者は、1カ月後に有効4名、無効6名で改善率40
%、2カ月後に有効5名、無効5名で改善率50%、3
カ月後に有効8名、無効2名で改善率80%であった。
B群の患者は、1カ月後に有効1名、無効9名で改善率
10%、2カ月後に有効2名、無効8名で改善率20
%、3カ月後に有効4名、無効6名で改善率40%であ
った。C群の患者は、1カ月後に有効4名、無効6名で
改善率40%、2カ月後に有効5名、無効5名で改善率
50%、3カ月後に著効1名、有効8名、無効1名で改
善率90%であった。臨床試験の結果をまとめて第2表
に示す。
From the results shown in Table 1, the improvement rate of the group A patients who received the thyme extract was higher than that of the group B patients who received the sesame oil, and the thyme extract was more allergenic than the sesame oil. It was found that the rhinitis has a strong antiallergic property. Furthermore, unexpectedly, the improvement rate of the group C patients receiving the mixture of thyme extract and sesame oil was higher than that of the group A patients receiving only the thyme extract. The effect is shown early in patients with
Since many patients in the group showed remarkable effects, it was found that the combined use of thyme extract and perilla oil produced a remarkable synergistic effect. Example 9 (Clinical test for atopic dermatitis) 30 patients with atopic dermatitis (18 male, 12 female, 5)
(~ 32 years old) was divided into 3 groups of A group, B group and C group by 10 persons each, and a clinical study was conducted for 3 months. Patients in Group A were administered with the anti-allergic food containing the thyme extract prepared in Example 3, patients in Group B were administered with the food containing DHA oil prepared in Comparative Example 2, and Group C was administered. 2% by weight of thyme extract and DH prepared in Example 4
An antiallergic food containing a mixture of 98% by weight of oil A was administered. As the test method, 5 g of thyme extract, DHA oil or a food containing thyme extract and DHA oil was orally administered to each patient at a rate of 5 g each day. On the other hand, there were no particular restrictions on bathing and meals during the test. Diagnosis is 1 month after the start of the test, 2
The test was carried out three times after and three months later. Judgment of the effect
Based on the opinions of the subject and the tester, excellent, valid, invalid,
The evaluation was made in four stages of deterioration. In addition, the improvement rate was obtained by dividing the total number of patients who were markedly effective and effective by the number of subjects. After 1 month, patients in group A were 4 effective and 6 ineffective, and the improvement rate was 40.
%, Improvement rate 50% after 5 months with 5 effective and 5 ineffective 3
After 8 months, the improvement rate was 80% with 8 effective and 2 ineffective.
After 1 month, patients in group B had an improvement rate of 10% with 9 effective cases and an improvement rate of 20%, and 2 months later with 2 effective cases and 8 invalid cases showing an improvement rate of 20.
%, 3 months later, the effective rate was 4 and the invalid rate was 6 and the improvement rate was 40%. Patients in Group C had 4 effective and 6 ineffective after 1 month, 40% improvement rate after 2 months, 5 effective 50% after 2 months, 50% improvement rate after 3 months, 1 excellent response, 8 effective response, The improvement rate was 90% for one invalid person. The results of the clinical trials are summarized in Table 2.

【0012】[0012]

【表2】 [Table 2]

【0013】第2表の結果から、タイム抽出物を投与し
たA群の患者の改善率は、DHA油を投与したB群の患
者の改善率より高く、タイム抽出物がDHA油よりも、
アトピー性皮膚炎において抗アレルギー性が強いことが
分かった。さらに、全く予期しないことに、タイム抽出
物のみを投与したA群の患者と、タイム抽出物2重量%
とDHA油98重量%の混合物を投与したC群の患者を
比較すると、改善率は同等あるいはC群の患者の方がわ
ずかに高く、効果が顕著でないDHA油に少量のタイム
抽出物を加えることにより、タイム抽出物を100%用
いた場合と同等又はそれ以上の効果が発現することが分
かった。 実施例10(抗アレルギー性の試験) 5週齢のマウス(DDY:雌)10匹を、5匹ずつA群
及びB群に分け、A群のマウスには粉末飼料[CE−
2、日本クレア(株)製品]を、B群のマウスにはこの粉
末飼料98重量%と製造例1のタイム抽出物2重量%の
混合物を、それぞれ4週間自由に摂取させた。3週間目
にジニトロフェニルベンゼンの0.5重量%エタノール
溶液100μlをマウスの腹部に塗布した。さらに、4
週間目にジニトロフェニルベンゼンの0.2重量%オリ
ーブオイル溶液20μlをマウスの両耳に塗布し、塗布
後と24時間後にアレルギーに起因する耳たぶの腫れを
ノギスで測定し、それぞれの群について平均値と標準偏
差を求めた。
From the results shown in Table 2, the improvement rate of the group A patients who received the thyme extract was higher than that of the group B patients who received the DHA oil.
It was found that the atopic dermatitis has a strong antiallergic property. Moreover, quite unexpectedly, patients in group A who received only thyme extract and 2% by weight of thyme extract.
Compared with patients in group C who received a mixture of 98% by weight and DHA oil, the improvement rate was similar or slightly higher in patients in group C, and adding a small amount of thyme extract to DHA oil was not effective. According to the above, it was found that an effect equivalent to or higher than the case where 100% thyme extract was used was exhibited. Example 10 (Anti-allergic test) 10 5-week-old mice (DDY: female) were divided into groups A and B, 5 mice each, and a powder feed [CE-
2, a product of CLEA Japan Co., Ltd.], mice of group B were allowed to freely ingest a mixture of 98% by weight of this powdered feed and 2% by weight of the thyme extract of Production Example 1 for 4 weeks. Three weeks later, 100 μl of a 0.5 wt% ethanol solution of dinitrophenylbenzene was applied to the abdomen of the mouse. In addition, 4
During the week, 20 μl of a 0.2% by weight solution of dinitrophenylbenzene in olive oil was applied to both ears of the mouse, and swelling of the earlobe caused by allergy was measured with a caliper after and 24 hours after the application, and the average value for each group was measured. And the standard deviation was calculated.

【0014】[0014]

【表3】 [Table 3]

【0015】第3表の結果から、本発明の抗アレルギー
食品を摂取したマウスの耳たぶの腫れは、粉末飼料のみ
を与えた群と比較して有意に小さく、本発明の抗アレル
ギー食品が抗アレルギー性を有することが確認された。 実施例11(抗アレルギー性の試験) 5週齢のマウス(DDY:雌)40匹を、5匹ずつC
群、D群、E群、F群、G群、H群、I群及びJ群に分
け、C群のマウスには粉末飼料[CE−2、日本クレア
(株)製品]のみを、D群のマウスにはこの粉末飼料95
重量%と製造例3のタイム抽出物5重量%の混合物を、
H群のマウスにはこの粉末飼料99重量%と実施例5の
タイム抽出物のボラージ油懸濁液1重量%の混合物を、
I群のマウスにはこの粉末飼料95重量%と実施例6の
タイム抽出物のDHA油懸濁液5重量%の混合物を、J
群のマウスにはこの粉末飼料90重量%と実施例7のタ
イム抽出物のエゴマ油懸濁液10重量%の混合物を、そ
れぞれ4週間自由に摂取させた。また、E群、F群及び
G群のマウスには、それぞれ第4表に示す粉末飼料と油
脂の混合物を、4週間自由に摂取させた。3週間目に、
ジニトロフェニルベンゼンの0.5重量%エタノール溶
液100μlを、マウスの腹部に塗布した。さらに、4
週間目にジニトロフェニルベンゼンの0.2重量%オリ
ーブオイル溶液20μlをマウスの両耳に塗布し、塗布
直後と24時間後に、アレルギーに起因する耳たぶの腫
れをノギスで測定し、それぞれの群について平均値と標
準偏差を求めた。タイム抽出物を摂取しないC群のマウ
スの耳たぶの腫れは、平均0.42mmであった。また、
タイム抽出物を摂取したD群のマウスの耳たぶの腫れ
は、平均0.29mmであった。油脂を摂取したE群、F
群及びG群のマウスの耳たぶの腫れは、それぞれ0.3
2mm、0.27mm及び0.28mmであった。さらに、タイ
ム抽出物と油脂の混合物を摂取したH群、I群及びJ群
のマウスの耳たぶの腫れは、それぞれ0.15mm、0.1
6mm及び0.16mmであった。投与飼料、耳たぶの腫れ
の平均値及び標準偏差を、まとめて第4表に示す。
From the results shown in Table 3, the swelling of the earlobe of the mice ingested with the antiallergic food of the present invention was significantly smaller than that in the group fed with the powdered feed alone. It was confirmed that the product has sex. Example 11 (Anti-allergenicity test) Forty five-week-old mice (DDY: female), each including five mice, C
Group D, group E, group F, group G, group H, group I and group J, powdered feed [CE-2, CLEA Japan,
[Products Co., Ltd.]
% By weight and 5% by weight of the thyme extract of Preparation Example 3,
To the mice of group H, a mixture of 99% by weight of this powdered feed and 1% by weight of a suspension of thyme extract of Example 5 in borage oil,
For Group I mice, a mixture of 95% by weight of this powdered feed and 5% by weight of a DHA oil suspension of the thyme extract of Example 6 was used.
A group of mice was allowed to freely ingest a mixture of 90% by weight of this powdered feed and 10% by weight of a suspension of thyme extract of Example 7 in perilla oil for 4 weeks. The mice of groups E, F, and G were allowed to freely ingest the mixture of the powdered feed and the oil and fat shown in Table 4 for 4 weeks. In the third week,
100 μl of a 0.5 wt% ethanol solution of dinitrophenylbenzene was applied to the abdomen of the mouse. In addition, 4
During the week, 20 μl of a 0.2% by weight solution of dinitrophenylbenzene in olive oil was applied to both ears of the mouse. Immediately after and 24 hours after the application, the swelling of the earlobe caused by allergy was measured with a caliper, and the average for each group was measured. Values and standard deviations were determined. The swelling of the earlobe of the mice of group C not ingesting the thyme extract was 0.42 mm on average. Also,
The swelling of the earlobe of the mice of group D receiving the thyme extract was 0.29 mm on average. Group E, F who took oils and fats
The swelling of the earlobe of the mice of group G and group G was 0.3, respectively.
It was 2 mm, 0.27 mm and 0.28 mm. Further, the swelling of the earlobe of the mice of the H group, the I group and the J group, which ingested the mixture of the thyme extract and the fat and oil, was 0.15 mm and 0.1, respectively.
It was 6 mm and 0.16 mm. The average value and standard deviation of the administered feed, earlobe swelling are summarized in Table 4.

【0016】[0016]

【表4】 [Table 4]

【0017】第4表の結果から、タイム抽出物を摂取し
たD群のマウスの耳たぶの腫れ、油脂を摂取したE群、
F群及びG群のマウスの耳たぶの腫れは、粉末飼料のみ
を摂取したC群のマウスの耳たぶの腫れと比較して有意
に小さく、タイム抽出物、ボラージ油、DHA油及びエ
ゴマ油が、いずれも抗アレルギー性を有することが確認
された。さらに、タイム抽出物とこれらの油脂の混合物
を摂取したH群、I群及びJ群のマウスの耳たぶの腫れ
は、タイム抽出物のみ又は油脂のみを摂取したD群、E
群、F群及びG群のマウスの耳たぶの腫れと比較してさ
らに有意に小さく、タイム抽出物と油脂が相乗的な抗ア
レルギー性を発揮することが分かった。 実施例12(抗補体活性の測定) タイム抽出物、タイム抽出物と油脂の混合物及び油脂に
ついて、常法[進藤美由記ら、和漢薬、第16巻、76
頁(1983年)]により抗補体活性を測定した。ま
た、比較対照として、精製水及び抗アレルギー性のある
漢方薬紫朴湯を用いて測定を行った。試験液は、A群が
精製水のみであり、B群が紫朴湯、C群がタイム抽出
物、D群がボラージ油、E群がDHA油、F群がエゴマ
油、G群がタイム抽出物20重量%とエゴマ油80重量
%の混合物、H群がタイム抽出物10重量%とボラージ
油90重量%の混合物、I群がタイム抽出物1重量%と
DHA油99重量%の混合物を、いずれも精製水に1重
量%添加し、超音波により均一に分散した液である。ヒ
ト血清と0.15mM塩化カルシウム、0.5mM塩化マ
グネシウム、0.1%ゲラチンを含むベロナール緩衝液p
H7.5(GVB++)及び試験液を各50μl混合し、こ
れを37℃において30分間反応させたのち、GVB++
で段階希釈し、ヒツジ感作血球を加えTCH5Oを測定
した。試験液の代わりに、PBS-を反応させた際のT
CH5Oを100とし、試験液によるTCH5Oの減少
率をもって抗補体活性とした。抗補体活性は、精製水の
みを用いたA群は0.0%であり、紫朴湯を用いたB群
は59.2%であり、タイム抽出物を用いたC群は54.
1%であった。また、ボラージ油、DHA油及びエゴマ
油を用いたD群、E群及びF群は、それぞれ36.3
%、35.0%及び30.3%であった。また、タイム抽
出物とともに、エゴマ油を併用したG群、ボラージ油を
併用したH群及びDHA油を併用したI群は、それぞれ
79.2%、76.2%及び73.6%であった。試験に
供した試料の組成及び抗補体活性を、まとめて第5表に
示す。
From the results shown in Table 4, the swelling of the earlobe of the mice of the group D receiving the thyme extract, the group E receiving the oil and fat,
The swelling of the ear lobes of the mice of the F group and the G group was significantly smaller than that of the mice of the C group receiving only the powdered feed, and thyme extract, borage oil, DHA oil, and perilla oil were all Was also confirmed to have anti-allergic properties. Furthermore, the swelling of the earlobe of the mice of the H group, the I group and the J group, which ingested the mixture of thyme extract and these oils and fats, was observed in the D group and the E group, which ingested only the thyme extract or the oils and fats.
It was found that the thyme extract and the oil / fat exert synergistic antiallergic properties, which are significantly smaller than the swelling of the earlobe of the mice of the F group, the F group and the G group. Example 12 (Measurement of anti-complement activity) Regarding thyme extract, mixture of thyme extract and fats and oils and fats and oils, a conventional method [Miyuki Shindo et al., Japanese and Chinese medicine, Volume 16, 76.
Page (1983)], the anti-complement activity was measured. As a comparative control, the measurement was performed using purified water and anti-allergic Chinese herbal medicine Saibokuto. In the test solution, the group A is pure water only, the group B is shibokuto, the group C is thyme extract, the group D is borage oil, the group E is DHA oil, the group F is sesame oil, and the group G is thyme extract. A mixture of 20% by weight of the product and 80% by weight of sesame oil, a group H a mixture of 10% by weight of the thyme extract and 90% by weight of borage oil, and a group I of a mixture of 1% by weight of the thyme extract and 99% by weight of DHA oil, Both are solutions in which 1% by weight is added to purified water and uniformly dispersed by ultrasonic waves. Veronal buffer p containing human serum and 0.15 mM calcium chloride, 0.5 mM magnesium chloride, 0.1% gelatin
50 μl each of H7.5 (GVB ++ ) and the test solution were mixed and allowed to react at 37 ° C. for 30 minutes, and then GVB ++
Was serially diluted with, sheep sensitized blood cells were added, and TCH5O was measured. Instead of the test solution, PBS - T when reacted with
CH5O was set to 100 and the decrease rate of TCH5O by the test solution was used as the anti-complement activity. The anti-complementary activity was 0.0% in the group A using pure water, 59.2% in the group B using Saiboku-to, and 54.4 in the group C using thyme extract.
1%. In addition, group D, group E and group F using borage oil, DHA oil and perilla oil were 36.3 each.
%, 35.0% and 30.3%. In addition, G group using sesame oil, H group using borage oil and I group using DHA oil together with thyme extract were 79.2%, 76.2% and 73.6%, respectively. . The composition and anti-complement activity of the samples used in the test are summarized in Table 5.

【0018】[0018]

【表5】 [Table 5]

【0019】第5表の結果から、タイム抽出物は、抗ア
レルギー性のある漢方薬として知られている紫朴湯の抗
アレルギー性をわずかに下まわる程度の抗アレルギー性
を有することが分かる。また、ボラージ油、DHA油及
びエゴマ油は、それぞれ単独では紫朴湯より抗アレルギ
ー性がかなり低い。しかし、タイム抽出物とこれらの油
脂を併用することにより、抗補体活性の値が高くなり、
相乗効果により優れた抗アレルギー性を発揮することが
分かった。
From the results shown in Table 5, it can be seen that the thyme extract has an antiallergic effect which is slightly lower than that of Saibokuto known as an antiallergic Chinese medicine. In addition, borage oil, DHA oil, and perilla oil each have considerably lower antiallergic properties than shibokuto. However, the combined use of these oils and fats with thyme extract increases the value of anti-complement activity,
It was found that the synergistic effect exerts excellent antiallergic properties.

【0020】[0020]

【発明の効果】現在、成人では花粉症が、また小児では
アトピー性皮膚炎が増加しているにもかかわらず、これ
らの予防法、治療法は確立されてはいない。本発明のタ
イム抽出物を含有する抗アレルギー食品は、天然物より
構成されているために安全であり、これまでの抗炎症
剤、抗ヒスタミン薬剤などにたよる治療法とは異なり、
副作用を伴うことなく、抗アレルギー症状の予防及び治
療を効果的に行うことができる。
Although pollinosis is increasing in adults and atopic dermatitis is increasing in children, the preventive and therapeutic methods for these have not been established yet. The anti-allergic food containing the thyme extract of the present invention is safe because it is composed of natural products, and unlike conventional therapeutic methods based on anti-inflammatory agents, antihistamines, etc.,
It is possible to effectively prevent and treat anti-allergic symptoms without causing side effects.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】タイム抽出物を含有することを特徴とする
抗アレルギー食品。
1. An anti-allergic food containing a thyme extract.
【請求項2】タイム抽出物及び油脂を含有することを特
徴とする抗アレルギー食品。
2. An anti-allergic food containing thyme extract and fats and oils.
【請求項3】油脂がエゴマ油である請求項2記載の抗ア
レルギー食品。
3. The antiallergic food according to claim 2, wherein the fat or oil is perilla oil.
【請求項4】油脂がDHA油である請求項2記載の抗ア
レルギー食品。
4. The antiallergic food according to claim 2, wherein the fat or oil is DHA oil.
【請求項5】油脂がボラージ油である請求項2記載の抗
アレルギー食品。
5. The antiallergic food according to claim 2, wherein the fat or oil is borage oil.
【請求項6】油脂が月見草油である請求項2記載の抗ア
レルギー食品。
6. The antiallergic food according to claim 2, wherein the oil and fat is evening primrose oil.
JP8212016A 1995-11-06 1996-07-23 Antiallergic food Pending JPH09187248A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8212016A JPH09187248A (en) 1995-11-06 1996-07-23 Antiallergic food

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-311536 1995-11-06
JP31153695 1995-11-06
JP8212016A JPH09187248A (en) 1995-11-06 1996-07-23 Antiallergic food

Publications (1)

Publication Number Publication Date
JPH09187248A true JPH09187248A (en) 1997-07-22

Family

ID=26518965

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8212016A Pending JPH09187248A (en) 1995-11-06 1996-07-23 Antiallergic food

Country Status (1)

Country Link
JP (1) JPH09187248A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523920A (en) * 1998-06-01 2003-08-12 ピーター, ヒュー ハル, Use of nugari nut oil for the treatment / reduction of the development of arthritis and similar symptoms
JP2007230977A (en) * 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd Production inhibitor ii for granulocyte/macrophage colony stimulating factor (gm-csf)
JP2010088441A (en) * 2001-12-11 2010-04-22 Soc Des Produits Nestle Sa Composition for promotion of bone growth and maintenance of bone health
JP2020145941A (en) * 2019-03-12 2020-09-17 日本製粉株式会社 Allergic rhinitis inhibitory composition
WO2020209701A1 (en) * 2019-04-12 2020-10-15 이연제약 주식회사 Composition for alleviating, treating, or preventing skin diseases, containing thymus vulgaris extract
KR20200120556A (en) * 2019-04-12 2020-10-21 이연제약주식회사 Composition for improving, preventing or treating skin disease comprising Thymus plant extract

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523920A (en) * 1998-06-01 2003-08-12 ピーター, ヒュー ハル, Use of nugari nut oil for the treatment / reduction of the development of arthritis and similar symptoms
JP2010088441A (en) * 2001-12-11 2010-04-22 Soc Des Produits Nestle Sa Composition for promotion of bone growth and maintenance of bone health
JP2007230977A (en) * 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd Production inhibitor ii for granulocyte/macrophage colony stimulating factor (gm-csf)
JP2020145941A (en) * 2019-03-12 2020-09-17 日本製粉株式会社 Allergic rhinitis inhibitory composition
WO2020209701A1 (en) * 2019-04-12 2020-10-15 이연제약 주식회사 Composition for alleviating, treating, or preventing skin diseases, containing thymus vulgaris extract
KR20200120556A (en) * 2019-04-12 2020-10-21 이연제약주식회사 Composition for improving, preventing or treating skin disease comprising Thymus plant extract

Similar Documents

Publication Publication Date Title
JP7069490B2 (en) Yuricoma longifolia extract and its use in enhancing and / or stimulating the immune system
DE602004006860T2 (en) CAPSAICINOID-CONTAINING PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN110267672A (en) Pharmaceutical composition comprising Qingdai extract or fraction thereof as active ingredient for preventing or treating inflammatory bowel disease
CN104004583A (en) Natural health plant oil containing linoleic acid and linolenic acid as well as preparation method and application of plant oil
JP2011148726A (en) Beauty set for improving flabbiness and beauty method using the same
EP0391218B1 (en) Agent for the atopy prophylaxis
KR20060047367A (en) In vivo Radical Capture Compositions
JPH09278662A (en) Antiallergic agent
JPH09291299A (en) Antiallergic oil and fat composition and use
JPH09187248A (en) Antiallergic food
CN105101817B (en) Edible composition and preparation method thereof and the food comprising said composition
JP4824205B2 (en) Female hormone abnormal disorder improving agent
JP3761510B2 (en) Foods that improve or prevent hay fever
JP2004352626A (en) Anti-cholesterol agent containing plant-derived components
KR101881663B1 (en) Earthworm fermented extracts and method for manuracturing thereof and natural cosmetics and functional health food comprising same
DE202008015430U1 (en) Composition for the treatment of indigestion
CN108271893A (en) Blood fat reducing tea
CN109954052A (en) A kind of composition with antioxidant activity
JP4105498B2 (en) A composition effective for prevention and alleviation of symptoms of atopic disease
JP2002205954A (en) Blood circulation improver
JPH0662795A (en) Antiallergic food
KR20180056199A (en) Manufacturing method of gum for diet containing Moringa Oleifera extract
JPH09234019A (en) Antiallergic food and antiallergic agent
JP2002173434A (en) Antiallergic composition
JPH0959167A (en) Healthy food medicine and its preparation